ACE2 and COVID-19: Surprisingly, our genetic dissection of ACE2 in COVID-19 reveals that lung infection by SARS-CoV-2 is neither required nor sufficient for acute lung injury, hypoxemia, and death following infection of otherwise healthy hACE2fl/y mice.